IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (254)	12/19/1996 9:24:00 PM
From: I. Luttichuys	of 1762

Hello Brad, This is good and timely news with IDEC showing some strength as of late. I find it interesting that the numbers have come down but just as interesting, if not odd, is that fact that they left out toxicities. I am thinking with C2B8 out on the market, it may be difficult to get and maintain market share for Coulter is there is not an improvement with toxicities. To justify the extra inconvenience and expense to the patient, Coulter's solution will have to have very competitive efficacy and toxicity profiles. Brad, I want to thank you for that post. I am on a flight to San Francisco tomorrow for the holidays. I will be checking in as I find myself with access to a computer. I believe that in a previous post you may have mentioned you are married and so I would like to wish you and your wife a Merry Christmas and a very Happy New Year now in the event I am not in touch before I return to NY on 5 January. All the best, BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next